Auro Laboratories Share Price
259.25+4.20 (+1.65%)
+15.07% past 1 Year
Auro Laboratories limited is a manufacturer of Active Pharmaceutical Ingredients (APIs), Intermediates and Generic Formulations. The company was founded and incorporated in 1992 at Mumbai, with a manufacturing facility located
Corporate filings & documents
Announcements
Auro Laboratories Limited has submitted the clippings of newspaper publications of the Un-audited Financial Results for the quarter ended June 30 2026.
2 weeks agoAuro Laboratories Limited has submitted the clippings of newspaper publications of the Un-audited Financial Results for the quarter ended June 30 2026.
2 weeks agoAuro Laboratories Limited has submitted the Unaudited Financial Results for the Quarter ended June 30 2026.
2 weeks agoAuro Laboratories Limited has submitted the Unaudited Financial Results for the Quarter ended June 30 2026.
2 weeks agoAuro Laboratories Limited has submitted the Outcome of the Board Meeting held on August 14 2026
2 weeks agoAuro Laboratories Limited has submitted the Outcome of the Board Meeting held on August 14 2026
2 weeks agoAuro Laboratories Limited has submitted the Scrutinizer Report of 37th AGM held on August 11 2026.
3 weeks agoAuro Laboratories Limited has submitted the Scrutinizer Report of 37th AGM held on August 11 2026.
3 weeks agoAuro Laboratories Limited has submitted the Proceedings/Outcome of the 37th Annual General Meeting held on August 11 2026.
3 weeks agoAuro Laboratories Limited has submitted the Proceedings/Outcome of the 37th Annual General Meeting held on August 11 2026.
3 weeks agoAuro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Financial Results for the Quarter ended 30 June 2026 and any other matter with the permission of the chair.
3 weeks agoAuro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Financial Results for the Quarter ended 30 June 2026 and any other matter with the permission of the chair.
3 weeks agoWith reference to Regulation 47 of SEBI (LODR) Regulations 2015 attached herewith newspaper cuttings of Public Notice of the 37th AGM information on evoting and other related information.
1 month agoWith reference to Regulation 47 of SEBI (LODR) Regulations 2015 attached herewith newspaper cuttings of Public Notice of the 37th AGM information on evoting and other related information.
1 month agoThe Letter being send to the shareholders containing the web-link of the Annual Report of the Company for the FY 2025-2026 is enclosed.
1 month agoThe Letter being send to the shareholders containing the web-link of the Annual Report of the Company for the FY 2025-2026 is enclosed.
1 month agoEnclosed Annual report of the Company for the FY 2025-2026
1 month agoEnclosed Annual report of the Company for the FY 2025-2026
1 month agoEnclosed Notice of 37th Annual General Meeting of the Company scheduled on August 11 2026 at 11:30a.m. (IST)
1 month agoEnclosed Notice of 37th Annual General Meeting of the Company scheduled on August 11 2026 at 11:30a.m. (IST)
1 month agoAuro Laboratories Limited has submitted the Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026.
1 month agoAuro Laboratories Limited has submitted the Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026.
1 month agoAuro Laboratories Limited has submitted the Newspaper Publication regarding intimation of 37th AGM of the Company.
1 month agoAuro Laboratories Limited has submitted the Newspaper Publication regarding intimation of 37th AGM of the Company.
1 month agoAuro Laboratories Limited hereby approve the re-appointment of Mr. Kiran Suresh Kulkarni as a Whole Time Director.
2 months agoAuro Laboratories Limited hereby approve the re-appointment of Mr. Kiran Suresh Kulkarni as a Whole Time Director.
2 months agoAuro Laboratories Limited scheduled the Board Meeting on June 30 2026 to transact the business matter which are attached herewith.
2 months agoAuro Laboratories Limited scheduled the Board Meeting on June 30 2026 to transact the business matter which are attached herewith.
2 months agoAuro Laboratories Limited has informed about the Closure of Trading Window.
2 months agoAuro Laboratories Limited has informed about the Closure of Trading Window.
2 months agoEnclosed herewith Newspaper Advertisement
3 months agoEnclosed herewith Newspaper Advertisement
3 months agoEnclosed herewith Annual Secretarial Compliance Report for the Year Ended March 31 2026.
3 months agoEnclosed herewith appointment of Chief Financial Officer Tax Auditor Internal Auditor and Reappointment of Cost Auditor.
3 months agoEnclosed herewith appointment of Chief Financial Officer Tax Auditor Internal Auditor and Reappointment of Cost Auditor.
3 months agoEnclosed herewith Financial Results for the year ended March 31 2026
3 months agoEnclosed herewith Financial Results for the year ended March 31 2026
3 months agoPursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at their meeting held today i.e. May 29 2026 inter-alia considered the matters as enclosed herewith.
3 months agoAuro Laboratories Limited has submitted the Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 for Resignation of Mr. Kuntal Pancholi as the Chief Financial Officer & Key Managerial Personnel of the Company w.e.f May 28 2026.
3 months agoAuro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Audited Financial Results of the Company along with Report of the Auditors for the Quarter and Year Ended March 31 2026 and any other matter with the permission of the Chair.
3 months agoAuro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Audited Financial Results of the Company along with Report of the Auditors for the Quarter and Year Ended March 31 2026 and any other matter with the permission of the Chair.
3 months agoAuro Laboratories Limited submits that the Company has received a "Certification of Substances Department" from the European Directorate for the Quality of Medicines & Healthcare ("EDQM") for the Companys Manufacturing facility situated at M.I.D.C Tarapur Maharashtra.
4 months agoAuro Laboratories Limited submits that the Company has received a Certificate of GMP Compliance of a Manufacturer from Swissmedic Swiss Agency for Therapeutic Products for the Companys manufacturing facility situated at M.I.D.C Tarapur Maharashtra.
4 months agoAuro Laboratories Limited has submitted the Disclosure in relation to Credit Rating obtained by the Company from Acuite Ratings & Research Limited.
4 months agoAuro Laboratories Limited has submitted the Disclosure in relation to Credit Rating obtained by the Company from Acuite Ratings & Research Limited.
4 months agoAuro Laboratories Limited has submitted the Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended March 31 2026.
4 months agoIntimation for Closure of Trading Window
5 months agoIntimation for Closure of Trading Window
5 months agoAuro Laboratories Limited has submitted the clippings of Newspaper Publication of the Unaudited Financial Results of the Quarter and Nine Months ended December 31 2025.
6 months agoAuro Laboratories Limited has submitted Financial Results for the quarter ended December 31 2025.
7 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
K 56 M I D C Industrial Area Boisar Tarapur Thane Maharashtra PIN: 401506 Tel No: 022- 56635456 Fax No: 022- 56635460 Email: [email protected] Internet: www.aurolabs.com
Registrars
Gala No 9, Shiv Shakti, Industrial EstateSitaram Mill Compound, J R Boricha Marg Gala No 9 Shiv Shakti, Industrial Estate,Sitaram Mill Comp. J R Boricha Marg, Lower Parel [E] PIN: Tel No: +91 22 4134 3255/ +91 22 4134 3256 Fax No: NULL Email: [email protected] Internet: www.purvashare.com
Management
Sharat Deorah, Chairman & Managing Director
Sharat Deorah, Chairman & Managing Director
Siddhartha Deorah, Whole Time Director
Kiran Kulkarni, Whole Time Director
Kavita Vijayakant Sharma, Independent Non-Executive Director
Vishal Kailashchandra Jhunjhunwala, Independent Non-Executive Director
Mahendra Kumar Daga, Independent Non-Executive Director
Padma Tapariya, Company Secretary & Compliance Officer
Details
BSE 530233
NSE NULL
ISIN INE292C01011